| STAT3 establishes an immunosuppressive microenvironment during the early stages of breast carcinogenesis to promote tumor growth and metastasis LM Jones, ML Broz, JJ Ranger, J Ozcelik, R Ahn, D Zuo, J Ursini-Siegel, ... Cancer research 76 (6), 1416-1428, 2016 | 115 | 2016 |
| CD44 promotes PD-L1 expression and its tumor-intrinsic function in breast and lung cancers T Kong, R Ahn, K Yang, X Zhu, Z Fu, G Morin, R Bramley, NC Cliffe, Y Xue, ... Cancer research 80 (3), 444-457, 2020 | 108 | 2020 |
| The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression R Ahn, V Sabourin, AM Bolt, S Hébert, S Totten, N De Jay, MC Festa, ... Nature communications 8 (1), 14638, 2017 | 59 | 2017 |
| Deciphering the immunopeptidome in vivo reveals new tumour antigens AM Jaeger, LE Stopfer, R Ahn, EA Sanders, DA Sandel, WA Freed-Pastor, ... Nature 607 (7917), 149-155, 2022 | 46 | 2022 |
| Analyzing the tumor microenvironment by flow cytometry YK Young, AM Bolt, R Ahn, KK Mann The Tumor Microenvironment: Methods and Protocols, 95-110, 2016 | 43 | 2016 |
| STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer SP Totten, YK Im, E Cepeda Cañedo, O Najyb, A Nguyen, S Hébert, ... Nature Communications 12 (1), 3299, 2021 | 38 | 2021 |
| p66ShcA promotes breast cancer plasticity by inducing an epithelial-to-mesenchymal transition J Hudson, JR Ha, V Sabourin, R Ahn, R La Selva, J Livingstone, ... Molecular and cellular biology 34 (19), 3689-3701, 2014 | 33 | 2014 |
| The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression R Ahn, V Sabourin, JR Ha, S Cory, G Maric, YK Im, WR Hardy, H Zhao, ... Cancer research 73 (14), 4521-4532, 2013 | 20 | 2013 |
| p66ShcA functions as a contextual promoter of breast cancer metastasis K Lewis, A Kiepas, J Hudson, J Senecal, JR Ha, E Voorand, MG Annis, ... Breast Cancer Research 22, 1-19, 2020 | 19 | 2020 |
| The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation A Kiepas, E Voorand, J Senecal, R Ahn, MG Annis, K Jacquet, G Tali, ... Journal of Biological Chemistry 295 (31), 10535-10559, 2020 | 15 | 2020 |
| Clinical potential of kinase inhibitors in combination with immune checkpoint inhibitors for the treatment of solid tumors R Ahn, J Ursini-Siegel International Journal of Molecular Sciences 22 (5), 2608, 2021 | 14 | 2021 |
| Interplay between ShcA signaling and PGC-1α triggers targetable metabolic vulnerabilities in breast cancer YK Im, O Najyb, SP Gravel, S McGuirk, R Ahn, DZ Avizonis, V Chénard, ... Cancer Research 78 (17), 4826-4838, 2018 | 14 | 2018 |
| Integration of distinct ShcA signaling complexes promotes breast tumor growth and tyrosine kinase inhibitor resistance JR Ha, R Ahn, HW Smith, V Sabourin, S Hébert, E Cepeda Cañedo, ... Molecular Cancer Research 16 (5), 894-908, 2018 | 14 | 2018 |
| Antigen discovery for the development of cancer immunotherapy R Ahn, Y Cui, FM White Seminars in Immunology 66, 101733, 2023 | 10 | 2023 |
| p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors EC Cañedo, S Totten, R Ahn, P Savage, D MacNeil, J Hudson, C Autexier, ... JCI insight 6 (4), 2021 | 5 | 2021 |
| Characterizing signaling in macrophage-GBM cell coculture AD D'Souza, R Mukkamala, R Ahn, FM White Cancer Research 84 (6_Supplement), 5365-5365, 2024 | | 2024 |
| Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model JB Iorgulescu, N Ruthen, R Ahn, E Panagioti, PC Gokhale, M Neagu, ... Frontiers in immunology 14, 1297932, 2023 | | 2023 |
| DIPG-39. SIGNALING NETWORKS IN PEDIATRIC-TYPE DIFFUSE HIGH GRADE GLIOMAS SA Herbst, R Ahn, S Agnihotri, M Zapotocky, FM White Neuro-Oncology 25 (Suppl 1), i22, 2023 | | 2023 |
| Assessment of The Impact of Oncolytic Virotherapy on The Immunopeptidome Profile of Tumor by Utilizing GEMM Derived Immunocompetent GBM Models R Piranlioglu, R Ahn, H Nakashima, A Islam, R Guda, A Charest, ... The Journal of Immunology 210 (1_Supplement), 245.11-245.11, 2023 | | 2023 |
| Investigative needle core biopsies for multi-omics in Glioblastoma KKH Yu, S Basu, G Bacquer, R Ahn, J Gantchev, S Jindal, MS Regan, ... medRxiv, 2023.12. 29.23300541, 2023 | | 2023 |
Josie Ursini-SiegelProfessor, Lady Davis Institute for Medical Research, McGill UniversityVerified email at mcgill.ca
